Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Valbiotis SA (8JD) Stock Price & Analysis

0 Followers

8JD Stock Chart & Stats

€0.58-€0.00(-0.69%)
At close: 5:30 PM GMT+1
€0.65€0.7€0.75€0.8Sep 25Oct 12Oct 13Nov 2
Day’s Range
EUR 0.58 - EUR 0.58
52-Week Range
EUR 0.49 - EUR 1.26
Previous Close
EUR 0.58
Volume
N/A
Average Volume (3M)
161
Market Cap
EUR 21.32M
Enterprise Value
EUR 12.83M
Total Cash (Recent Filing)
EUR 8.68M
Total Debt (Recent Filing)
EUR 5.09M
Price to Earnings (P/E)
―
Beta
-0.20
Next Earnings
Mar 17, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Metabolic-health Focus

Valbiotis is focused on cardiometabolic and metabolic health, areas aligned with preventative nutrition and long-term health management. A defined therapeutic-nutrition focus can support coherent product development and commercialization across related needs.

Revenue Rebound

The reported 183.47% revenue growth indicates meaningful recent commercial expansion from the company’s low base. If maintained through broader product adoption or distribution, this growth could improve operating leverage and strengthen the platform’s ability to fund development.

Multiple Commercialization Routes

Valbiotis’s model permits several routes to monetization, including product sales, ingredient supply, and rights granted to partners. This flexibility can broaden market access and create opportunities for recurring commercial income as formulations progress toward wider use.

Bears Say

Persistent Unprofitability

Deep losses and negative gross profit show that current revenue does not cover the cost base, limiting operating self-sufficiency. Unless scale materially improves cost absorption, continued deficits can constrain reinvestment and prolong dependence on external funding.

Ongoing Cash Burn

Multi-year negative operating and free cash flow indicate that the business is not yet self-funding. Continued cash consumption raises the need for external capital, which can reduce financial flexibility and create dilution risk while products are developed and commercialized.

Shrinking Equity Base

Declining equity and assets, combined with persistently negative returns on equity, indicate erosion of the financial base supporting operations. If losses continue, Valbiotis may have less balance-sheet flexibility and greater exposure to value dilution from future capital needs.

Valbiotis SA News

8JD FAQ

What was Valbiotis SA’s price range in the past 12 months?
Valbiotis SA lowest stock price was €0.49 and its highest was €1.26 in the past 12 months.
What is Valbiotis SA’s market cap?
Valbiotis SA’s market cap is €21.32M.
When is Valbiotis SA’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Valbiotis SA’s earnings last quarter?
Valbiotis SA released its earnings results on Oct 12, 2026. The company reported -€0.095 earnings per share for the quarter.
Is Valbiotis SA overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Valbiotis SA pay dividends?
Valbiotis SA does not currently pay dividends.
What is Valbiotis SA’s EPS estimate?
Valbiotis SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Valbiotis SA have?
Valbiotis SA has 35,538,235 shares outstanding.
What happened to Valbiotis SA’s price movement after its last earnings report?
Valbiotis SA reported an EPS of -€0.095 in its last earnings report. Following the earnings report the stock price went up 13.082%.
Which hedge fund is a major shareholder of Valbiotis SA?
Currently, no hedge funds are holding shares in DE:8JD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology